"Cefoperazone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections.
Descriptor ID |
D002438
|
MeSH Number(s) |
D02.065.589.099.249.150.160 D02.886.665.074.150.160 D03.633.100.300.249.150.160
|
Concept/Terms |
Cefoperazone Sodium- Cefoperazone Sodium
- Sodium, Cefoperazone
- Cefoperazone Sodium Salt
- Salt, Cefoperazone Sodium
- Sodium Salt, Cefoperazone
|
Below are MeSH descriptors whose meaning is more general than "Cefoperazone".
Below are MeSH descriptors whose meaning is more specific than "Cefoperazone".
This graph shows the total number of publications written about "Cefoperazone" by people in this website by year, and whether "Cefoperazone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cefoperazone" by people in Profiles.
-
Metagenomic Alterations in Gut Microbiota Precede and Predict Onset of Colitis in the IL10 Gene-Deficient Murine Model. Cell Mol Gastroenterol Hepatol. 2021; 11(2):491-502.
-
Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. J Lab Clin Med. 1995 Feb; 125(2):200-11.
-
In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia. Drugs. 1995; 49 Suppl 2:246-9.
-
Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model. Diagn Microbiol Infect Dis. 1991 Mar-Apr; 14(2):147-55.
-
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy. J Lab Clin Med. 1990 Nov; 116(5):697-706.
-
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model. J Lab Clin Med. 1990 Feb; 115(2):190-5.
-
Influence of protein binding on therapeutic efficacy of cefoperazone. Antimicrob Agents Chemother. 1989 Apr; 33(4):566-8.